These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6777331)

  • 1. Role of hyaluronidase in immediate hypersensitivity reaction.
    Sakamoto K; Nagai H; Koda A
    Immunopharmacology; 1980 Apr; 2(2):139-46. PubMed ID: 6777331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on vascular permeability increasing factors involved in 48-hour homologous PCA in the mouse ear.
    Inagaki N; Goto S; Yamasaki M; Nagai H; Koda A
    Int Arch Allergy Appl Immunol; 1986; 80(3):285-90. PubMed ID: 3087885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effects of glucocorticoids on increased vascular permeability caused by passive cutaneous anaphylaxis and some chemical mediators in rats.
    Inagaki N; Miura T; Nagai H; Koda A
    Jpn J Pharmacol; 1988 Feb; 46(2):189-92. PubMed ID: 3379829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immediate inhibitory effect of methylprednisolone suleptanate (U-67590A) on antigen-induced cutaneous and airway anaphylactic responses in guinea-pigs.
    Hashimoto M; Shinozaki Y; Katori M
    Br J Pharmacol; 1993 Mar; 108(3):604-12. PubMed ID: 7682130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of immediate hypersensitivity reactions in the rat by disodium cromoglycate and nitroindanedione.
    Spicer BA; Ross JW; Smith H
    Clin Exp Immunol; 1975 Sep; 21(3):419-29. PubMed ID: 812623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-allergic effects of ketanserin on animal models of allergic reactions.
    Nagai H; Suda H; Kitagaki K; Goto S; Miura T; Koda A
    Arch Int Pharmacodyn Ther; 1990; 307():172-82. PubMed ID: 1710442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiallergic effect of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidaz ole difumarate (KB-2413).
    Fukuda T; Saito T; Tajima S; Shimohara K; Ito K
    Arzneimittelforschung; 1984; 34(7):805-10. PubMed ID: 6208915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immediate inhibition by oral l-ephedrine of passive cutaneous anaphylaxis of rats: indirect inhibition of anaphylactic chemical mediator release from the mast cell.
    Shibata H; Minami E; Hirata R; Mizutani N; Nabe T; Kohno S
    Inflamm Res; 2000 Oct; 49(10):553-9. PubMed ID: 11089909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-allergic properties of ethyl-3-methoxyphenyl-4-thiazolyl-2-oxamate (F 1865).
    Tarayre JP; Lauressergues H; Fauran F
    Arch Int Pharmacodyn Ther; 1982 Nov; 260(1):165-76. PubMed ID: 6187305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of TYB-2285 on passive cutaneous anaphylaxis in rats.
    Watanabe A; Tominaga T; Shutoh H; Hayashi H; Tsuji J; Koda A; Nagai H; Kumazawa Y; Shimada H
    Gen Pharmacol; 1997 Feb; 28(2):311-5. PubMed ID: 9013210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
    Levrier J; Duval D; Prouteau M; Voltz C; Berry CN; Lloyd KG; Scatton B
    Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of SA-103 on experimental allergic models in vivo and in vitro--comparison with disodium cromoglycate.
    Nabe T; Yamamura H; Kohno S; Ohata K
    Arerugi; 1992 Jun; 41(6):676-85. PubMed ID: 1280084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of involvement of leukotriene and platelet activating factor in passive cutaneous anaphylaxis in rats.
    Taira M; Kohno SW; Yamamura H; Ohata K
    Agents Actions; 1988 Jun; 24(1-2):189-95. PubMed ID: 3407549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological properties of N-(3',4'-dimethoxycinnamoyl) anthranilic acid (N-5'), a new anti-atopic agent.
    Azuma H; Banno K; Yoshimura T
    Br J Pharmacol; 1976 Dec; 58(4):483-8. PubMed ID: 63304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An experimental asthma model in unanesthetized rat, and the difference in effect of disodium cromoglycate between passive cutaneous anaphylaxis model and asthma model in rat.
    Kuriyama K; Ichikawa K
    J Pharmacobiodyn; 1982 Oct; 5(10):751-9. PubMed ID: 6819356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effects of beta-adrenergic stimulants on increased vascular permeability caused by passive cutaneous anaphylaxis, allergic mediators, and mediator releasers in rats.
    Inagaki N; Miura T; Daikoku M; Nagai H; Koda A
    Pharmacology; 1989; 39(1):19-27. PubMed ID: 2479953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased vascular permeability during passive peritoneal anaphylaxis in the rat. The effects of disodium cromoglycate and a nitroindanedione.
    Ross JW; Smith H; Spicer BA
    Int Arch Allergy Appl Immunol; 1976; 51(2):226-37. PubMed ID: 58838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-allergic action of glucocorticoids in rats.
    Nagai H; Takizawa T; Nakatomi I; Matsuura N; Koda A
    Jpn J Pharmacol; 1983 Apr; 33(2):349-55. PubMed ID: 6193304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Kinetic measurement of cutaneous anaphylactic reactions in rats].
    Schnitzler S; Baumann A; Renner H; Klein H; Reitnauer PG
    Z Med Lab Diagn; 1981; 22(1):23-8. PubMed ID: 6785937
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmacological studies on oxatomide (KW-4354): (1) Effect on passive cutaneous anaphylaxis (PCA)].
    Ohmori K; Ishii H; Hirayama T; Shuto K; Nakamizo N
    Nihon Yakurigaku Zasshi; 1982 Sep; 80(3):251-60. PubMed ID: 6130032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.